JAN 05, 2016 03:13 PM PST

Prevent Ebola From Mutating, Prevent It From Returning

WRITTEN BY: Kara Marker
There’s no rest for the weary, and that includes researchers looking for a definitive cure and treatment plan for Ebola patients. Even though Guinea was declared free of the hemorrhagic disease just before ringing in the new year, the threat of the virus evolving to be more dangerous and evasive than before has kept scientists on the hunt for a final answer.

Ebola is caused by an RNA virus whose genome encodes proteins such as nucleoprotein, glycoprotein, and L protein that are all sealed in a viral envelope (Kenyon College). Although there currently are vaccines that target these vital structural proteins to prevent Ebola virus from infecting host cells, a few different strains of the deadly disease exist that vary enough in amino acid and nucleotide sequencing to make a general vaccine impossible to create.

To make matters worse, the Ebola virus also contains to potential to evolve, and this is what scientists from the Texas Biomedical Research Institute wanted to investigate in a new Journal of Virology publication.
 

 
"Any change in a genome can be neutral, negative, or positive to a virus," Anthony Griffiths, PhD, explained. "Interestingly, viruses appear to have evolved to have an optimal mutation rate. Increasing the mutation rate could produce a negative effect on the virus and serve as a valuable therapeutic tool."

Griffiths explained that they will not have to prevent Ebola from mutating all together, just stimulate enough stress to increase the mutation rate so viral cells are weakened and inviable.

"We found that Ebola virus had very limited ability to tolerate spontaneous changes in the genome,” he said.

They tested a drug for chronic hepatitis C, called ribavirin, to see if Ebola cells faltered like they predicted they would after meddling with the viral mutation rate. Ribavirin is a nucleoside inhibitor that prevents viruses from synthesizing RNA and viral mRNA capping (Merck). Although the team saw successful clinical trials in mice and monkey subjects, further studies are required to make ribavirin a substantial candidate for treating Ebola.
 
The fight against Ebola in Guinea

Source: Texas Biomedical Research Institute
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 24, 2018
Cell & Molecular Biology
AUG 24, 2018
Chronic Allergies can Change Cells
Chronic rhinosinusitis is different from allergies; it leads to serious inflammation and swelling in the sinuses that can last for years....
AUG 28, 2018
Genetics & Genomics
AUG 28, 2018
A New Type of Cell is Discovered in the Human Brain
This cell type has never been observed in laboratory animals....
SEP 02, 2018
Genetics & Genomics
SEP 02, 2018
Insights From the Opium Poppy Genome
By sequencing the opium poppy's DNA, scientists have revealed important details about how it makes its medicine....
SEP 27, 2018
Genetics & Genomics
SEP 27, 2018
Learning What Causes Algae Blooms to Turn Toxic
According to the EPA, algal blooms threaten every state and in our changing climate, they may be more common....
SEP 28, 2018
Genetics & Genomics
SEP 28, 2018
How Genes Changed in Domesticated Foxes
Over fifty years ago, scientists in Russia began to selectively breed silver foxes to replicate domestication....
OCT 11, 2018
Videos
OCT 11, 2018
An Inexpensive Kit Teaches Kids About Molecular Biology
Biology is advancing at a rapid pace. Students will be ready for those advances if they can learn about cutting-edge concepts at an early age....
Loading Comments...